it's the end of the year and volume today is really low. I do agree that they are pretty misguided and going after indications with little patient volume and making extremely expensive drugs. They better pull something out of their butttts fast in 2013 or this one will be going the way of the typewriter companies.
thank you. You've got to admit they aren't a small MRK, GSK, AZN, LLY, PFE etc... They are a small niche firm with the big boys breathing down their back. I'm glad for the run from 38 to 46. Need over 50's so I'm still stuck in this stuff.